Previous studies have demonstrated that tumor infiltrating lymphocytes(TILs), especially the CD4+ T cells and CD8+ T cells, are correlated with clinical prognosis in gliomas [25, 26]. The gene discussed is CD4; the disease is central nervous system cancer.